ARTICLE | Management Tracks
CFO André Muller to succeed Clozel as CEO
By Stephen Hansen, Director of Biopharma Intelligence
May 21, 2024 10:09 PM UTC
After nearly 27 years at the helm of leading European biotech Actelion and its successor Idorsia, Jean-Paul Clozel is retiring as CEO and will stand for election as chairman of the Swiss biotech. Longtime CFO André Muller will take over the top executive spot on June 13.
Mathieu Simon, the current chair, will stand for re-election to the board, with an eye toward taking on the role of vice-chairman and lead independent director…
- SEO Powered Content & PR Distribution. Get Amplified Today.
- PlatoData.Network Vertical Generative Ai. Empower Yourself. Access Here.
- PlatoAiStream. Web3 Intelligence. Knowledge Amplified. Access Here.
- PlatoESG. Carbon, CleanTech, Energy, Environment, Solar, Waste Management. Access Here.
- PlatoHealth. Biotech and Clinical Trials Intelligence. Access Here.
- Source: https://www.biocentury.com/article/652483/clozel-looks-to-next-chapter-as-idorsia-chair